Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05676814
Other study ID # IRB00090669
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 24, 2023
Est. completion date June 24, 2023

Study information

Verified date April 2024
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this randomized, triple-blinded, prospective, feasibility study is to compare postoperative analgesia provided by Pecto-intercostal Fascial Block (PIFB) when performed with local anesthetic solution with or without perineural adjuvants in patients following cardiac surgery involving sternotomy. The study team hypothesizes that the patients receiving PIFB with bupivacaine with epinephrine, clonidine, and dexamethasone will have lower dynamic pain over the first 36 hours compared to those receiving PIFB with just bupivacaine and epinephrine.


Description:

This will be a randomized, triple-blinded, prospective, feasibility trial. Written informed consent will be obtained from all study participants prior to randomization. Patients scheduled to undergo cardiac surgery involving sternotomy at Atrium Health Wake Forest Baptist will be screened for eligibility. These patients will be approached for enrollment by research staff either during their preoperative assessment clinic visit prior to their surgery date, or when admitted as inpatients and scheduled for surgery. Subjects chosen to participate will be randomized into one or other arm and PIFB will be performed after skin closure and before transport from the operating room to the ICU. For patients who are randomized at enrollment but later excluded due to exclusion criteria prior to block placement, their randomization assignment will be replaced at the end of the initial recruitment.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date June 24, 2023
Est. primary completion date June 23, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Adults between undergoing cardiac surgery involving sternotomy Exclusion Criteria: - Patients with any contraindications to regional anesthesia, such as history of allergy to amide local anesthetics or any of the perineural adjuvants - existing neurologic deficit in the chest wall; - remaining intubated at the six hour point after block placement - weight under 50kg - undergoing emergency surgical procedures or urgent return to the operating room - active endocarditis or mediastinitis - moderate to severe right ventricular function before or after cardiopulmonary bypass - reliance on mechanical circulatory support devices, such as intra-aortic balloon pump or Impella - reliance on extracorporeal membrane oxygenation - localized or systemic infection - chronic use of high dose opioid analgesics (defined as daily use greater than 30 oral morphine milligram equivalents (OMME) for over one month prior to surgery) - those who are pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Pecto-intercostal Fascial Block (PIFB)
PIFB done with bupivacaine and epinephrine
PIFB with adjuvants
PIFB with bupivacaine, epinephrine, clonidine, and dexamethasone

Locations

Country Name City State
United States Wake Forest Health Sciences Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores Based on patient-reported dynamic Numerical Rating Scale (NRS) pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 0 to 6 hrs after placement. 0 to 6 hours after block placement
Primary Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 12 hours after block placement
Primary Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 18 hours after block placement
Primary Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 24 hours after block placement
Primary Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 36 hours after block placement
Secondary Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest Pain scores range from 0 to 10 with higher scores denoting more pain. 6 hours after block placement
Secondary Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest Pain scores range from 0 to 10 with higher scores denoting more pain. 6, 12, 18, 24 hours after block placement
Secondary Average Cumulative Opioid Consumption Average Cumulative Opioid Consumption in milligrams 36 hours after block placement
Secondary Average Time to First Opioid Administration Average Time to First Opioid Administration - Postoperative after extubation measured in minutes Up to 36 hours after block placement
Secondary Average Time to Extubation Average Time to Extubation - measured in minutes Up to 36 hours after block placement
Secondary Duration of Intensive Care Unit (ICU) Admission Duration of Intensive Care Unit (ICU) Admission - measured in Average number of hours. Up to 52 hours after block placement
Secondary Incentive Spirometry Volumes An incentive spirometer is a handheld medical device that measures the volume of subject's breath. The volume of air displaced is indicated in milliliters on a scale located on the device enclosure. This device measures what is called vital capacity, the amount of air that is breathed in and out of the lungs. 6, 12, 18, 24 hours after block placement
Secondary Safety Outcome: Nausea Incidence Average number of incidences of Nausea Up to 36 hours after block placement
Secondary Safety Outcome: Vomiting Incidence Average number of Vomiting incidences Up to 36 hours after block placement
Secondary Safety Outcome: Postoperative Delirium Incidence Average number of Delirium incidences Up to 36 hours after block placement
Secondary Numeric Rating Scale (NRS) Satisfaction With the Analgesic Regimen Patient-reported scores range from 0-10 where 0 represents completely unsatisfied and 10 represents completely satisfied. 36 hours after block placement
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05534230 - Dexmedetomidine for Pain Reduction in CABG N/A
Recruiting NCT06275698 - HONEY for the Treatment of POst-Tonsillectomy Pain N/A
Recruiting NCT04436224 - Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation Phase 4
Not yet recruiting NCT04548323 - Hypoalgesic Effects of Walking and Running Imagined
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT04394481 - Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery Phase 4
Completed NCT04690647 - The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. N/A
Completed NCT05034601 - ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05454202 - Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
Recruiting NCT04554186 - Serratus Anterior Plane Block Versus Thoracic Paravertebral Block. N/A
Not yet recruiting NCT06393777 - Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion N/A
Suspended NCT04860635 - Safety of F14 Following Total Knee Replacement Phase 2/Phase 3
Not yet recruiting NCT04519463 - The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing Early Phase 1
Completed NCT02916342 - Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks Phase 4
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Not yet recruiting NCT02549118 - Tenoxicam for Intrapartum Analgesia Phase 2
Not yet recruiting NCT02190760 - Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block. N/A
Completed NCT01789606 - Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet Phase 3
Completed NCT01299584 - ULTIVA Post Marketing Surveillance N/A